LDLR and autoimmune polyendocrinopathy: Because one of the residues (K308) in β2GP1 domain V is involved in binding to LDL receptor ApoER2 and these interactions have been implicated in the pathogenicity of APS (38), we introduced a point mutation K308A, K308D, and K308S and generated three variants of FL15.